Clinical TrialsSearch results
Number of results: 201
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Prospective multicenter clinical study evaluating efficacy and safety of Nilotinib in Ph chromosome-positive (Ph+) CML patients with Imatinib resistance or intolerance
- Chronic myelogenous leukemia
- East Japan CML Study Group (EJCML)
- 2009-07-15
Other
- PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
- Chronic Myeloid Leukemia (chronic phase)
- Inter-Michinoku Dasatinib Study(IMIDAS)
- 2009-04-23
Other
- Randomized Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary
- clear cell carcinoma of the ovary
- Japanese Gynecologic Oncology Group
- 2006-10-10
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10
Other
- Biomarker-Cohort Study of Adjuvant Chemotherapy for Stage III Colon Cancer
- Colon cancer
- Tokyo Medical and Dental University
- 2009-05-29
Other
- Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal dysfunction following colon surgery
(a randomized, double-blind, multi-center, placebo-controlled study)
- Colon cancer including RS cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-01
Other
- A multicenter phaseII study of FOLFIRI as FOLFOX refractory second-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with honozygous for UGT1A1: (FLIGHT2)
- colorectal cancer
- NPO Epidemiological and Clinical Research Information Network
- 2009-09-10
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03
Other
- Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type
- Colorectal Cancer
- Epidemiological and Clinical Research Information Network (ECRIN)
- 2009-06-22